Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 37 of the 40 references it cites were found in a registry or an index.

Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial

Abstract

Background Calcium antagonists are widely prescribed for angina pectoris but their effect on clinical outcome is controversial. We aimed to investigate the effect of the calcium antagonist nifedipine on long-term outcome in patients with stable angina pectoris.Methods We randomly assigned 3825 patients with treated stable symptomatic coronary disease to double-blind addition of nifedipine GITS (gastrointestinal therapeutic system) 60 mg once daily and 3840 to placebo. The primary endpoint was the combination of death, acute myocardial infarction, refractory angina, new overt heart failure, debilitating stroke, and peripheral revascularisation. Mean follow-up was 4.9 years (SD 1.1). Analysis was by intention to treat.Findings 310 patients allocated nifedipine died (1.64 per 100 patient-years) compared with 291 people allocated placebo (1.53 per 100 patient-years; hazard ratio 1.07 [95% CI 0.91-1.25], p=0.41). Primary endpoint rates were 4.60 per 100 patient-years for nifedipine and 4.75 per 100 patient-years for placebo (0.97 [0.88-1.07], p=0.54). With nifedipine, rate of death and any cardiovascular event or procedure was 9.32 per 100 patient-years versus 10.50 per 100 patient-years for placebo (0.89 [0.83-0.95], p=0.0012). The difference was mainly attributable to a reduction in the need for coronary angiography and interventions in patients assigned nifedipine, despite an increase in peripheral revascularisation. Nifedipine had no effect on the rate of myocardial infarction.Interpretation Addition of nifedipine GITS to conventional treatment of angina pectoris has no effect on major cardiovascular event-free survival. Nifedipine GITS is safe and reduces the need for coronary angiography and interventions.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(04)16980-8

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 40 references

Research works printed but not linked: 1

  1. Lubsen, 1998, Design and current status of ACTION: A Coronary disease Trial Investigating Outcome with Nifedipine GITS, Eur Heart J, 19, I20

Cited by

See all 511

Metadata

Authors
Poole-Wilson, P. A., Lubsen, J., Kirwan, B.-A., van Dalen, F. J., Wagener, G., Danchin, N., Just, H., Fox, K. A., Pocock, S. J., Clayton, T. C., Motro, M., Parker, J. D., Bourassa, M. G., Dart, A. M., Hildebrandt, P., Hjalmarson, Å., Kragten, J. A., Molhoek, G. P., Otterstad, J.-E., Seabra-Gomes, R., Soler-Soler, J., & Weber, S.
Affiliations
  • Imperial College London (GB)
  • Erasmus MC (NL)
  • State Oil Company of Azerbaijan Republic (Azerbaijan) (AZ)
  • Bayer (Germany) (DE)
  • Hôpital Européen Georges-Pompidou (FR)
  • University of Freiburg (DE)
  • University of Edinburgh (GB)
  • London School of Hygiene & Tropical Medicine (GB)
  • Tel Aviv University (IL)
  • Mount Sinai Hospital (CA)
  • Montreal Heart Institute (CA)
  • The Alfred Hospital (AU)
  • Frederiksberg Hospital (DK)
  • Sahlgrenska University Hospital (SE)
  • Atrium Medisch Centrum Parkstad (NL)
  • Medisch Spectrum Twente (NL)
  • Sykehuset i Vestfold (NO)
  • Hospital de Santa Cruz (PT)
  • Université Paris Descartes (FR)
Venue
The Lancet
Publisher
Elsevier BV
Published
2004-09
Volume
364
Issue
9437
Pages
849-857
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2121708260
Cited by
511
References
40
Citations by year
2026: 1 · 2025: 8 · 2024: 4 · 2023: 16 · 2022: 10 · 2021: 7 · 2020: 14 · 2019: 14 · 2018: 16 · 2017: 28 · 2016: 21 · 2015: 34 · 2014: 22 · 2013: 24 · 2012: 27
FWCI
31.21
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
Funders
  • Bayer
  • Bayer HealthCare
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords
nifedipine, stable angina, calcium channel blockers, cardiovascular mortality, cardiovascular morbidity, gastrointestinal therapeutic system, coronary angiography, revascularization, myocardial infarction, heart failure, stroke, event-free survival
MeSH terms
Angina Pectoris, Calcium Channel Blockers, Cardiovascular Diseases, Double-Blind Method, Female, Humans, Male, Middle Aged, Nifedipine, Survival Analysis, Endpoint Determination

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(04)16980-8
The paper
Poole-Wilson, P. A., Lubsen, J., Kirwan, B.-A., van Dalen, F. J., Wagener, G., Danchin, N., Just, H., Fox, K. A., Pocock, S. J., Clayton, T. C., Motro, M., Parker, J. D., Bourassa, M. G., Dart, A. M., Hildebrandt, P., Hjalmarson, Å., Kragten, J. A., Molhoek, G. P., Otterstad, J.-E., . . . Weber, S. (2004). Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(04)16980-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.